IV information · product identity under verification
IV Product Information
IV-drip information in Seoul with product-specific identity, route, screening, and evidence limits. Cindella-specific composition, benefit, pricing, and availability claims are on hold pending verification.
Board-Certified
Dermatologist
AAD International Fellow
IFAAD
- Duration
- Set after assessment
- Sessions
- No universal course
- Downtime
- Varies by plan
IV Product Information Overview
This page separates each authorized product from any clinic-prepared combination. Cindella-specific composition, cosmetic-benefit, pricing, and availability claims are not published until the exact product, ingredient, dose, route, handling, and consent language are verified.
- Duration
Set after assessment
- Sessions
No universal course
- Downtime
Varies by plan
- Peak result
Reassessed over time
How IV Product Information Works
01
Publication hold: confirm each exact product name, active ingredient, authorization number, dose, route, compatibility, sterility and handling process, consent language, and clinic availability.
01
Publication hold: confirm each exact product name, active ingredient, authorization number, dose, route, compatibility, sterility and handling process, consent language, and clinic availability.
“Injectables and energy devices are performed by physicians — never delegated to non-physician staff. The clinic is led by a board-certified dermatologist.”
FAQ
Is this IV treatment currently offered?
Availability, composition, dose, route, price, benefits, and booking are not published while operator, pharmacist, physician, and legal verification is pending.
Why is Cindella-specific information not listed?
The cited Korean product record identifies Cindella Injection as a thioctic-acid product. The clinic has not yet supplied the product, pharmacy, dose, combination, handling, consent, availability, and pricing records needed to publish a broader clinic formulation. Those claims remain on hold.
Session summary & comparison
| Item | Details |
|---|---|
| Duration | Set after assessment |
| Sessions | No universal course |
| Downtime | Varies by plan |
| Peak result | Reassessed over time |
References
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.1 ref
- [1]Cindella Injection product record. Korea Pharmaceutical Information Center using MFDS product data (2012).
Related procedures
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step